Sucampo (SCMP +0.6%) bucks a weak tape after saying that the Japanese Science and Technology...

|About: Sucampo Pharmaceuticals, Inc. (SCMP)|By:, SA News Editor

Sucampo (SCMP +0.6%) bucks a weak tape after saying that the Japanese Science and Technology Agency has adopted the company's unoprostone isopropyl ophthalmic solution into its Technology Transfer Program. As part of the program, Japanese development partner R-Tech Ueno has signed an agreement with the agency to provide the majority of funding for Phase 3 clinical development costs for its treatment of retinitis pigmentosa. SCMP is planning to file for FDA approval pending the successful trials.